Table 4. WOMAC meta-analysis results.
Study or subgroup | Experimental | Control | Weight | Std. Mean Difference | ||||
---|---|---|---|---|---|---|---|---|
Mean | SD | Total | Mean | SD | Total | IV, Random, 95% CI | ||
Chen et al., 2021 | 8.19 | 1.87 | 16 | 12.13 | 3.2 | 16 | 11.1% | -1.47 [-2.26, -0.67] |
Gomiero et al., 2017 | 30.6 | 3.18 | 32 | 29.0 | 2.86 | 32 | 14.6% | 0.52 [0.02, 1.02] |
Jahanjoo et al., 2019 | 22.07 | 1.29 | 30 | 21.17 | 1.24 | 30 | 14.3% | 0.70 [0.18, 1.22] |
Kelley Fitzerald et al., 2011 | 20.3 | 2.1 | 91 | 19.9 | 1.9 | 92 | 16.9% | 0.20 [-0.09, 0.49] |
Ojoawo et al., 2016 | 10.14 | 11.48 | 23 | 17.67 | 8.66 | 22 | 13.3% | -0.73 [-1.33, -0.12] |
Tunay et al., 2010 | 5.45 | 3.76 | 30 | 5.69 | 2.84 | 30 | 14.5% | -0.07 [-0.58, 0.44] |
Xiao et al., 2020 | 20.7 | 8.7 | 40 | 18.8 | 7.4 | 45 | 15.4% | 0.23 [-0.19, 0.66] |
Total (95% CI) | 262 | 267 | 100.0% | -0.02 [-0.44, 0.40] |
Heterogeneity: Tau 2 = 0.25; Chi 2 = 31.26, df = 6 (p < 0.0001); I 2 = 81%.
Test for overall effect: Z = 0.11 (p = 0.91).